Becton, Dickinson and Co.’s board of directors approved the company’s diabetes spinoff, and set a date of April 1 for the move. The announcement of Embecta Corp.’s approval came Feb. 1, along with a ...

It’s official: Embecta Corp. is now one of the largest pure-play diabetes management companies worldwide. On April 1, Franklin Lakes-based BD announced it completed the spinoff of its former Diabetes ...

BD, a leading global medical technology company, recently announced that its board of directors has approved the planned spinoff of its diabetes care business, which will be known as Embecta. The ...

FRANKLIN LAKES, N.J., Feb. 1, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of directors has approved the ...

Under the transaction terms, BD shareholders received one share of Embecta stock for every five shares of BD that they held as of March 22. The Embecta spinoff severs all financial ties to BD, which ...

BD has logged about $400 million in COVID test sales six months into in its fiscal year, amounting to nearly 90% of the total it expects to see before the end of September, as demand for testing ...

BD completed its spinout of Embecta on April 1. The new entity comprises BD’s entire diabetes business, which dates back to 1924 with the introduction of the company’s first specialized insulin ...

Over 2,000 employees globally serving more than 100 countries. FRANKLIN LAKES, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (NASDAQ: EMBC) and its employees around the world ...

FRANKLIN LAKES, N.J., Feb. 1, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced its board of directors has approved the ...

FRANKLIN LAKES, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (NASDAQ: EMBC) and its employees around the world celebrate its launch today as one of the largest global pure-play ...